Table: OncoTherapy Science - 9-MTH group results

OncoTherapy Science

02/02/2018 08:00

Feb 2 (Reuters)-  
             OncoTherapy Science Inc  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2017        Dec 31, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales            203 mln             234 mln                     
                 (-13.5 pct)         (+11.3 pct)                   
  Operating       loss 2.22           loss 2.20                    
  Recurring       loss 2.22           loss 2.21                    
  Net             loss 2.15           loss 2.20                    
  EPS          loss 14.60 yen      loss 14.96 yen                  
  Ann Div                                NIL              NIL      
  -Q2 div 
  -Q4 div                                NIL              NIL      
   
  NOTE - OncoTherapy Science Inc.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T 
  ((Tokyo Headline News Desk +813 6441 1812))